Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

PURPOSE: The addition of bisphosphonates to adjuvant therapy improves survival in postmenopausal breast cancer (BC) patients. We report a meta-analysis of four randomised trials of neoadjuvant chemotherapy (CT) +/− zoledronic acid (ZA) in stage II/III BC to investigate the potential for enhancing th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroep, J.R., Charehbili, A., Coleman, R.E., Aft, R.L., Hasegawa, Y., Winter, M.C., Weilbaecher, K., Akazawa, K., Hinsley, S., Putter, H., Liefers, G.J., Nortier, J.W.R., Kohno, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928630/
https://www.ncbi.nlm.nih.gov/pubmed/26722766
http://dx.doi.org/10.1016/j.ejca.2015.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928630/
https://www.ncbi.nlm.nih.gov/pubmed/26722766
http://dx.doi.org/10.1016/j.ejca.2015.10.011

Ejemplares similares